Anthony Doyle

Insider Reports History

Location
Durham, NC
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony Doyle:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Chief Financial Officer Common Stock 377,867 $2,792,437 $7.39 19 Dec 2024 Direct
BIOCRYST PHARMACEUTICALS INC Chief Financial Officer Emp. Stock Option (Right to Buy) 250,100 19 Dec 2024 Direct

Insider Reports Filed by Anthony Doyle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2024 3 -$18,187 4 Chief Financial Officer 23 Dec 2024, 16:11
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2024 1 -$59,412 4 Chief Financial Officer 17 Dec 2024, 16:06
BCRX BIOCRYST PHARMACEUTICALS INC 14 May 2024 1 +$202,191 4 Chief Financial Officer 15 May 2024, 07:19
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2023 1 -$15,016 4 Chief Financial Officer 20 Dec 2023, 16:35
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2023 3 -$35,204 4 Chief Financial Officer 18 Dec 2023, 16:37
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2022 2 $0 4 Chief Financial Officer 21 Dec 2022, 15:32
BCRX BIOCRYST PHARMACEUTICALS INC 15 Dec 2022 1 -$62,130 4 Chief Financial Officer 19 Dec 2022, 15:55
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2021 1 $0 4/A Chief Financial Officer 13 Jan 2022, 15:40
BCRX BIOCRYST PHARMACEUTICALS INC 23 Nov 2021 1 +$440,020 4 Chief Financial Officer 24 Nov 2021, 17:35